Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Measuring airway surface liquid depth in ex vivo mouse airways by X-ray imaging for the assessment of cystic fibrosis airway therapies
Author: Morgan, K.
Donnelley, M.
Paganin, D.
Fouras, A.
Yagi, N.
Suzuki, Y.
Takeuchi, A.
Uesugi, K.
Boucher, R.
Parsons, D.
Siu, K.
Citation: PLoS One, 2013; 8(1):1-6
Publisher: Public Library of Science
Issue Date: 2013
ISSN: 1932-6203
Statement of
Kaye S. Morgan, Martin Donnelley, David M. Paganin, Andreas Fouras, Naoto Yagi, Yoshio Suzuki, Akihisa Takeuchi, Kentaro Uesugi, Richard C. Boucher, David W. Parsons, Karen K. W. Siu
Abstract: In the airways of those with cystic fibrosis (CF), the leading pathophysiological hypothesis is that an ion channel defect results in a relative decrease in airway surface liquid (ASL) volume, producing thick and sticky mucus that facilitates the establishment and progression of early fatal lung disease. This hypothesis predicts that any successful CF airway treatment for this fundamental channel defect should increase the ASL volume, but up until now there has been no method of measuring this volume that would be compatible with in vivo monitoring. In order to accurately monitor the volume of the ASL, we have developed a new x-ray phase contrast imaging method that utilizes a highly attenuating reference grid. In this study we used this imaging method to examine the effect of a current clinical CF treatment, aerosolized hypertonic saline, on ASL depth in ex vivo normal mouse tracheas, as the first step towards non-invasive in vivo ASL imaging. The ex vivo tracheas were treated with hypertonic saline, isotonic saline or no treatment using a nebuliser integrated within a small animal ventilator circuit. Those tracheas exposed to hypertonic saline showed a transient increase in the ASL depth, which continued for nine minutes post-treatment, before returning to baseline by twelve minutes. These findings are consistent with existing measurements on epithelial cell cultures, and therefore suggest promise for the future development of in vivo testing of treatments. Our grid-based imaging technique measures the ASL depth with micron resolution, and can directly observe the effect of treatments expected to increase ASL depth, prior to any changes in overall lung health. The ability to non-invasively observe micron changes in the airway surface, particularly if achieved in an in vivo setting, may have potential in pre-clinical research designed to bring new treatments for CF and other airway diseases to clinical trials.
Keywords: Respiratory Mucosa; Trachea; Extracellular Fluid; Animals; Mice; Cystic Fibrosis; Radiography; Time Factors; Female; In Vitro Techniques
Rights: © 2013 Morgan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
RMID: 0020125779
DOI: 10.1371/journal.pone.0055822
Appears in Collections:Paediatrics publications

Files in This Item:
File Description SizeFormat 
hdl_79523.pdfPublished version482.04 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.